Overview

A Pharmacokinetic Study of MK-0941 After Multiple Daily Doses in Subjects With Type 2 Diabetes (MK-0941-012)(COMPLETED)

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
A study to test the pharmacokinetics after twice daily administration of MK-0941 or placebo in subjects with type 2 diabetes who have inadequate control on metformin.
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.